Sign in

Broad Institute

@broadinstitute.org
5.6K followers 350 following 133 posts

A multidisciplinary community of researchers with the mission to better understand the roots of disease and narrow the gap between new biological insights and impact for patients. Broadinstitute.org

PostsRepliesMedia
Reposted by Broad Institute
Human Cell Atlas @humancellatlas.org · 22h
We’re delighted to announce that the HCA Organizing Committee (OC) has selected Muzz Haniffa and Alexandra-Chloé Villani to be the next Co-Chairs of the HCA OC, and Shyam Prabhakar and Holger Heyn as co Vice-Chairs. #HumanCellAtlas @mhaniffa.bsky.social @hoheyn.bsky.social
143
Broad Institute @broadinstitute.org · 01/10/2026
Survey of mitochondria proteomes across eukaryotes explores organelle’s role, suggests it originated late in eukaryotic evolution, and highlights possible drug targets for tropical diseases.
broad.io
Catalog of mitochondria across life’s family tree unearths new roles for the cell’s powerhouse
Survey of mitochondrial proteomes across eukaryotic taxa reveals clues to the organelle’s origins and functions, and suggests possible new opportunities for treating parasitic infections.
000
Broad Institute @broadinstitute.org · 30/09/2026
New method allows scientists to connect disease-linked regulatory genetic variants to the genes they control. These variants are more likely to influence disease risk if they alter chromatin accessibility that then changes gene expression.
broad.io
Atlas of immune cells explains how genetic variants cause disease
A new method reveals which genetic variants are most important in disease and how cells “buffer” the expression of genes critical for health.
051
Reposted by Broad Institute
Masahiro Kanai @masakanai.bsky.social · 30/09/2026
Our single-nucleus immune multiome atlas is now out in @nature.com! 🧬 10M PBMCs from 1,108 @finngen.bsky.social donors recruited by Finnish Blood Service, profiled at @broadinstitute.org with chromatin accessibility and gene expression in the same nuclei, to trace how disease variants act 🧵👇
13417
Broad Institute @broadinstitute.org · 30/09/2026
The @novo-nordisk.bsky.social is renewing its commitment to Broad with a $53M investment. With Danish scientists, the Center will leverage massive-scale data, AI, and cellular models to decode the genetic drivers of type 2 diabetes and obesity. broad.io/NNFCRenewal
031
Broad Institute @broadinstitute.org · 16/09/2026
To aid in virus outbreak responses, Broad researchers from @sabetilab.bsky.social and @fathom.info created Delphy.bio, a free web tool to reconstruct how a virus is spreading and changing using viral genomic data, reducing a months-long task into one that takes hours.
broadinstitute.org
Software rapidly tracks viral variants with high accuracy
A new web-based program called Delphy assembles viral family trees at unprecedented speed to aid outbreak responses.
054
Broad Institute @broadinstitute.org · 02/09/2026
New method lets scientists watch gene activity unfold in living cells over time, by engineering cells to package their own RNA into virus-like particles they release, ready for researchers to collect and sequence.
broad.io
New method allows scientists to follow gene activity over time in the same cells
In the new method, cells package and export their RNA, enabling researchers to sequence and analyze the RNA without killing the cells.
050
Reposted by Broad Institute
thexavierlab.bsky.social @thexavierlab.bsky.social · 27/08/2026
New preprint from our collaboration with Caroline Uhler and @broadinstitute.org on TissueFormer, a new tool for predicting spatial gene expression from histology images at cellular resolution www.biorxiv.org/content/10.6...
biorxiv.org
Multi-Modal Foundation Model with Whole-Slide Attention Enables Transferrable Digital Pathology at Single-Cell Resolution
Paired histopathology and spatial transcriptomics data are advancing our understanding of tissue biology and disease, but modeling both modalities at single-cell resolution while mapping local and dis...
032
Reposted by Broad Institute
Beth Cimini 🔬💻📊 @bethcimini.bsky.social · 26/06/2026
A week-overdue 🧵on the newest paper from the Cimini lab- do you ever do spatial transcriptomics? If you do, and you want free extra phenotypic info, step in to learn more about "Evaluating integrative strategies for incorporating phenotypic features in spatial transcriptomics". 🧪 (1/x)
onlinelibrary.wiley.com
Evaluating integrative strategies for incorporating phenotypic features in spatial transcriptomics
Spatial transcriptomics (ST) encompass technologies that measure gene expression in tissue samples without disrupting their organisation, unlike other single-cell techniques. In imaging-based ST spec...
195
Broad Institute @broadinstitute.org · 12/08/2026
Nominations are now open for the 2027 Merkin Prize in Biomedical Technology! 🏆 This international $400,000 prize recognizes pathbreaking technologies that have improved human health through treatment, diagnosis, or prevention of disease. Learn more: merkinprize.org
012
Reposted by Broad Institute
Nature Biotechnology @natbiotech.nature.com · 12/08/2026
Mechanistic machine learning for prediction of prime editing outcomes - @broadinstitute.org @hhmi-science.bsky.social www.nature.com/articles/s41...
nature.com
Mechanistic machine learning for prediction of prime editing outcomes - Nature Biotechnology
OptiPrime incorporates prime-editing biochemistry to predict prime-editing outcomes.
075
Broad Institute @broadinstitute.org · 12/08/2026
OptiPrime, a new AI model from David Liu's lab, helps scientists choose the best pegRNAs to make a desired edit, avoiding slow and costly steps in the lab and streamlining development of gene-editing medicines for rare diseases.
broad.io
AI model streamlines prime editing
The tool, called OptiPrime, helps researchers more easily determine the best guide RNAs for efficient prime editing, avoiding costly, time-consuming steps in the lab.
021
Broad Institute @broadinstitute.org · 05/08/2026
The Cancer Dependency Map now includes data from dozens of 3D cancer models across 10 cancer types, revealing new dependencies and offering a more comprehensive resource for cancer research.
broad.io
Cancer Dependency Map now includes next-generation 3D cancer models
Broad scientists expand the DepMap by adding cancer organoids and demonstrate the models’ potential to fuel new discoveries.
142
Broad Institute @broadinstitute.org · 04/08/2026
This Thursday, August 6, at 6PM ET, join us in Cambridge, MA (or online) for a Broad Discovery Series talk with @jbuenrostro.bsky.social: Uncovering Adversity's "Molecular Scars." Register: broadinstitute.swoogo.com/bds2026
012
Reposted by Broad Institute
Nature Biotechnology @natbiotech.nature.com · 03/08/2026
Evolution of botulinum neurotoxin serotype X proteases to induce inflammatory cell death in cancer cells - @broadinstitute.org @hhmi-science.bsky.social www.nature.com/articles/s41...
nature.com
Evolution of botulinum neurotoxin serotype X proteases to induce inflammatory cell death in cancer cells - Nature Biotechnology
Directed evolution of proteases induces targeted, multipathway lytic cell death in cancer cells.
042
Reposted by Broad Institute
thexavierlab.bsky.social @thexavierlab.bsky.social · 04/08/2026
New work with Ben Medoff's lab, online now! ADAMTS14 regulates YAP-driven fibroblast activation in IPF. We define an ADAMTS14–collagen V–focal adhesion pathway that contributes to $fibrosis, highlighting ADAMTS14 as a potential therapeutic target. doi.org/10.1093/ajrc...
doi.org
ADAMTS14 is a Novel Modulator of Fibroblast Mechanoactivation in Pulmonary Fibrosis
AbstractRationale. Yes-associated protein (YAP)-mediated fibroblast mechanoactivation is an important driver of fibrosis in idiopathic pulmonary fibrosis (
101
Broad Institute @broadinstitute.org · 21/07/2026
Central to CTG is a platform strategy: tools, disease models, and clinical protocols developed for one program are shared across many — making genetic medicine faster, safer, and more accessible. (3/3)
030
Broad Institute @broadinstitute.org · 21/07/2026
Recent advances in programmable genetic medicines — including base and prime editing treatments tailored to a patient’s specific mutation — are paving the way toward a new model for treating rare disease. (2/3)
140
Broad Institute @broadinstitute.org · 21/07/2026
We're thrilled to announce the Center for Therapeutic Genetics (CTG) — a new collaboration between Broad, Boston Children’s Hospital, and Jackson Laboratory to develop genetic medicines for rare and ultra-rare diseases. (1/3)
broad.io
Broad Institute, Boston Children’s Hospital, and The Jackson Laboratory launch the Center for Therapeutic Genetics, a non-profit effort to develop genetic medicines for rare and ultra-rare diseases
The new collaboration aims to develop precision medicines, including base and prime editing, to treat patients with rare diseases, using infrastructure and repeatable practices the center will share w...
1123
Reposted by Broad Institute
Jason Buenrostro @jbuenrostro.bsky.social · 18/07/2026
Thank you Broad Institute of MIT and Harvard for this profile. The last 2 years have been an extraordinary moment of creativity and inspiration. If you’re interested in joining us, PM me! We’re building new methods, models and ML tools - we’re recruiting at all levels!
0239
Broad Institute @broadinstitute.org · 16/07/2026
Shaped by a tumultuous childhood, Broad researcher and epigenomic tool-maker @jbuenrostro.bsky.social pivots to studying the biology of stress and adversity and finding new ways to boost resilience.
broad.io
A bioengineer shifts his career to explore how life experiences change the body
Shaped by a tumultuous childhood, Jason Buenrostro pivots from technology development to studying the biology of stress and adversity and finding new ways to boost resilience.
013
Broad Institute @broadinstitute.org · 10/07/2026
Join us on Thursday, August 6, at 6PM ET in Cambridge, MA (or online) for a Broad Discovery Series talk with @jbuenrostro.bsky.social: Uncovering Adversity's "Molecular Scars." Register: broadinstitute.swoogo.com/bds2026
020
Reposted by Broad Institute
The Jackson Laboratory @jax.org · 09/07/2026
We're thrilled to announce that, along with @broadinstitute.org, @bostonchildrens.bsky.social, RARE Hope and partners, JAX was selected for ARPA-H THRIVE Award to advance gene editing platform for pediatric epilepsies and rare CNS diseases. 🧪🧬🧠
jax.org
The Jackson Laboratory, with the Broad Institute and partners, selected for ARPA-H THRIVE Award to advance gene editing platform for pediatric epilepsies and rare CNS diseases
Pediatric Epilepsies & Rare CNS Gene Editing Platform (PERC) accelerates the development of precision genetic medicines for severe childhood neurologic disease.
0122
Broad Institute @broadinstitute.org · 09/07/2026
PERC is also part of a broader coalition that includes Critical Path Institute, N=1 Collaborative, Global Genes, Worldwide Clinical Trials, Beam Therapeutics, Prime Medicine, and Mahzi Therapeutics. (5/5)
000
Broad Institute @broadinstitute.org · 09/07/2026
We are honored to collaborate with Boston Children’s Hospital, The Jackson Laboratory, Children’s Hospital Colorado, Children's Hospital of Philadelphia, Apertura Gene Therapy, Viralgen, Rare Epilepsy Network, RARE Hope, and the Dravet Syndrome Foundation. (4/5)
100
Broad Institute @broadinstitute.org · 09/07/2026
The platform pairs precision gene editors with a Broad-developed AAV vector engineered to cross the blood-brain barrier without neurosurgery — and brings together 12 organizations across science, medicine, manufacturing, regulatory strategy, and patient advocacy. (3/5)
100
Broad Institute @broadinstitute.org · 09/07/2026
Developmental and epileptic encephalopathies affect more than 3 million children worldwide, yet traditional drug development has largely left families without options. PERC aims to change that. (2/5)
100
Broad Institute @broadinstitute.org · 09/07/2026
We're thrilled to announce that a Broad-led consortium of 12 organizations has been selected to receive funding from @arpa-h.bsky.social under its THRIVE program to launch the Pediatric Epilepsies and Rare CNS (PERC) Gene Editing Platform. broad.io/ARPA-H (1/5)
broad.io
Broad-led consortium receives ARPA-H award to advance gene editing for rare pediatric epilepsy
Twelve organizations spanning gene editing science, clinical medicine, manufacturing, regulatory strategy, and patient advocacy aim to deliver first-in-human trial within three years. div.hero-section...
191
Reposted by Broad Institute
Alicia Martin @genetisaur.bsky.social · 08/07/2026
So excited to see this published! This method was a long time in the making and is now being widely used to balance scale with depth, especially for participants where unbiased sequencing approaches are so much more useful than arrays
21710
Broad Institute @broadinstitute.org · 08/07/2026
Broad scientists developed the Blended Genome Exome (BGE) sequencing method, which delivers high-quality, unbiased data at a lower cost than existing gold-standard methods and makes large-scale genetic studies more feasible. @genetisaur.bsky.social
broad.io
Low-cost genome sequencing approach is powering genetics research on mental illness and many other studies
The Blended Genome Exome approach delivers high-quality, unbiased genetic data at a quarter of the cost of the leading sequencing method.
041
Reposted by Broad Institute
Microsoft Research @msftresearch.bsky.social · 09/06/2026
New research in Nature Methods from Project Ex Vivo shows AI models learn more from diverse cell states than from scaled datasets alone, a finding that could reshape how therapies are matched to patients. msft.it/6013vgE8l
032
Broad Institute @broadinstitute.org · 15/06/2026
The 2026 Richard N. Merkin Prize in Biomedical Technology honors Graeme Clark, Erwin Hochmair, Ingeborg Hochmair, Michael Merzenich, and Blake Wilson for developing the modern cochlear implant — a device used by more than 1 million people worldwide.
broad.io
2026 Merkin Prize in Biomedical Technology awarded to pioneers of the modern cochlear implant
The $400,000 prize honors five researchers who developed the first medical device to generate a human sense through a direct neural interface, a groundbreaking tool used by more than one million peopl...
000
Broad Institute @broadinstitute.org · 15/06/2026
In three new studies, the David Liu lab has optimized key prime editing components (guide pegRNA motifs, reverse transcriptase stability, and delivery via lipid nanoparticles), addressing key bottlenecks that previously impeded its use in animals and human patients.
broadinstitute.org
Scientists improve nearly every aspect of prime editing, moving it closer to treating more genetic diseases
The advances in editing efficiency and delivery are important steps toward in vivo therapeutic prime editing.
042
Reposted by Broad Institute
Huntington's Disease Foundation @hdfcures.bsky.social · 11/06/2026
Won-Seok Lee @broadinstitute.org, receives the 2026 Nancy S. Wexler Young Investigator Prize, which is awarded annually to an early career researcher whose work reflects the highest caliber of excellence, diligence & creative thinking. Learn more: tinyurl.com/nswprize #curehd #huntingtonsdisease
002
Reposted by Broad Institute
Dana-Farber News @danafarbernews.bsky.social · 27/05/2026
New research in @natmed.nature.com by @danafarber.bsky.social’s Dr. Suzanne George and Dr. Bradley Bernstein reveals the clinical activity of FGFR inhibition in SDH-deficient GIST. ➡️bit.ly/497QeW8 @broadinstitute.org
Research news from Dana-Farber Cancer Institute
041
Reposted by Broad Institute
Elinor Karlsson @elinork.bsky.social · 14/05/2026
My May 20 (next Wednesday!) lecture at Broad: Turns out humans don't have all the answers. There is an untapped opportunity for innovation in medicine by exploring why other species are protected from diseases common in humans. Come and find out more!
131
Broad Institute @broadinstitute.org · 06/05/2026
Join us in Cambridge, MA (or online) for a Broad Discovery Series talk, “What Animal Superpowers Can Teach Us About Our Own DNA,” on Wednesday, May 20, at 6 pm ET with @elinork.bsky.social of @darwinsark.org. Register: broadinstitute.swoogo.com/Karlsson
040
Reposted by Broad Institute
gtexportal.bsky.social @gtexportal.bsky.social · 05/05/2026
NHP-dGTEx V1 derived data is available for download from @GTExPortal. NHP-dGTEx V1 contains 421 Macaque samples (372 RNA-seq and 49 WGS) from 50 subjects and 333 Marmoset samples (314 RNA-seq and 19 WGS) from 20 subjects. bit.ly/4lV8tmI
bit.ly
GTEx Portal
The Genotype-Tissue Expression (GTEx) project is an ongoing effort to build a comprehensive public resource to study tissue-specific gene expression and regulation. Samples were collected from 53 non-...
011
Reposted by Broad Institute
gtexportal.bsky.social @gtexportal.bsky.social · 05/05/2026
dGTEx V1 open access data is now available for download from @GTExPortal. dGTEx V1 contains 379 samples from 40 subjects. bit.ly/4rHwa3A #rnaseq
bit.ly
GTEx Portal
The Genotype-Tissue Expression (GTEx) project is an ongoing effort to build a comprehensive public resource to study tissue-specific gene expression and regulation. Samples were collected from 53 non-...
021
Broad Institute @broadinstitute.org · 04/05/2026
Broad researchers used their single-molecule tracking technology to reveal unexpected patterns of dimerization among EGFR family receptors, shedding light on their role in cancer. Learn more: broad.io/Peng-EGFR
051
Reposted by Broad Institute
Tom Ulrich (he/him) @scribblertom.com · 01/05/2026
Other mammals have so many abilities that we don't, but which could teach us a lot about health and disease. Join us for what promises to be a talk filled to the brim with great science and super-cute animal pictures!
012
Reposted by Broad Institute
adamjrubin.bsky.social @adamjrubin.bsky.social · 30/04/2026
Excited to share our paper out today in @science.org! We directed high-content, single-cell genetic screens to ask how a disordered adapter protein orchestrates the complex process of T cell activation. (1/4) www.science.org/doi/10.1126/...
science.org
Disordered protein LAT encodes relative levels of signaling pathways in T cell activation
The disordered adapter protein linker for activation of T cells (LAT) propagates T cell receptor signaling. To interrogate how LAT coordinates multiple downstream pathways, we developed a single-cell ...
13512
Broad Institute @broadinstitute.org · 27/04/2026
Have you ever wondered what animal superpowers can teach us about our own DNA? Join us in Cambridge, MA (or online) for a Broad Discovery Series talk on Wednesday, May 20 at 6 pm ET with Elinor Karlsson. Register: broadinstitute.swoogo.com/Karlsson
000
Broad Institute @broadinstitute.org · 22/04/2026
A new drug candidate designed to slow the progression of prion disease is entering a phase 1 clinical trial. The trial, led by Eric Minikel, codirector of Broad’s Prion Therapeutic Science program, will evaluate a divalent small interfering RNA (siRNA) drug candidate for safety and tolerability.
broad.io
Clinical trial of a prion disease drug candidate begins enrolling participants
It’s the first time the potential treatment, a small interfering RNA targeting the prion protein, is being tested in humans.
0197
Reposted by Broad Institute
thexavierlab.bsky.social @thexavierlab.bsky.social · 21/04/2026
Out now in @cp-cellhostmicrobe.bsky.social! In collaboration with Swiss clinicians, we built the largest nasal microbial gene atlas in infants w/ and w/o cystic fibrosis to date (cont.)
121
Broad Institute @broadinstitute.org · 15/04/2026
Wed., April 22; 9:00 AM - 12:00 pm; Poster Section 11, Poster Board 8, Poster Number 7029: “Engineering isogenic models harboring resistance mechanisms to the latest-generation EGFR inhibitor in non-small cell lung cancer.” (4/4)
000
Broad Institute @broadinstitute.org · 15/04/2026
Sunday, April 19; 4:20 pm; Ballroom 6 CF - Upper Level: “PRISM AIR: A high-throughput platform for functional validation of ADC targets and antibody candidate prioritization” Details about PRISM posters can be found at www.linkedin.com/company/pris.... Visit PRISM at booth #3017. (3/4)
linkedin.com
The PRISM Lab | LinkedIn
The PRISM Lab | 390 followers on LinkedIn. 900+ Cancer Cell Line Screening and Predictive Modeling of Drug Response | Developed by the Broad Institute of MIT and Harvard, PRISM (Profiling Relative Inh...
110
Broad Institute @broadinstitute.org · 15/04/2026
Attending #AACR? Stop by these Cancer Dependency Map activities: Saturday, April 18; 12:30 - 2:00 pm; Ballroom 6 DE - Upper Level - Convention Center: Join the DepMap team in celebrating their 2026 AACR Team Science Award at the Award Lecture. www.aacr.org/about-the-aa... (2/4)
aacr.org
AACR Announces 2026 Scientific Achievement Award Recipients
The AACR will honor the following cancer researchers and physician-scientists during the AACR Annual Meeting 2026, to be held April 17-22 at the San Diego Convention Center in San Diego, California.
100
Broad Institute @broadinstitute.org · 15/04/2026
The Cancer Dependency Map Consortium is entering its third phase, accelerating the next generation of cancer therapies. (1/4)
broadinstitute.org
Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics
The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.
111
Reposted by Broad Institute
broadmpg.bsky.social @broadmpg.bsky.social · 14/04/2026
The recording of "Network-based rare variant association for complex diseases" by @snz20.bsky.social is now available: youtu.be/KO-6M5lXTlI. This talk is part of @broadinstitute.org's MPG Primer series. For more info, check out broad.io/MPGPrimer.
012